Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors.

Expression from a short human cytomegalovirus (HCMV) major immediate early (IE) promoter-enhancer was tested in three different virus vectors: recombinant adenovirus (Ad), recombinant herpes simplex virus type 1 (HSV-1) and HSV-1-derived amplicon vectors. The HCMV major IE promoter-enhancer within a replication-deficient recombinant Ad vector was shown to produce cell-specific expression in rat nervous system cell cultures. Recombinant Ad entered all cell types examined but the HCMV major IE promoter was silent in primary cultures of neocortical neurons and Schwann cells, although it drove transgene expression in astrocytes and fibroblasts. Moreover, in neurons and Schwann cells, expression from the HCMV major IE promoter-enhancer in the replication-deficient Ad vector was activated by superinfection with HSV-1, replication-competent Ad and HCMV. The HCMV major IE promoter-enhancer was active in neurons when inserted into HSV-1 recombinant vectors. Further experiments with HSV-1-derived amplicons strongly suggested that an IE protein was responsible for the activation of HCMV major IE-induced expression in neurons. This demonstrates that the activity of the HCMV major IE promoter-enhancer element can depend on the expression of other genes encoded in the virus vector backbone within which it is inserted, and that it can function in a neuronal cell type-specific manner when inserted into a replication-deficient Ad vector.

[1]  G. Banker,et al.  Culturing nerve cells , 1998 .

[2]  P. Ghazal,et al.  The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice , 1996, Journal of virology.

[3]  R. MacLaren,et al.  Immunological Instability of Persistent Adenovirus Vectors in the Brain: Peripheral Exposure to Vector Leads to Renewed Inflammation, Reduced Gene Expression, and Demyelination , 1996, The Journal of Neuroscience.

[4]  J. Wilson,et al.  Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. , 1996, Virology.

[5]  M. Wood,et al.  Adenovirus gene transfer causes inflammation in the brain , 1995, Neuroscience.

[6]  P. Tomasec,et al.  Simultaneous detection of amplicon and HSV-1 helper encoded proteins reveals that neurons and astrocytoma cells do express amplicon-borne transgenes in the absence of synthesis of virus immediate early proteins. , 1995, Brain research. Molecular brain research.

[7]  P. Mitchell,et al.  Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection , 1995, Journal of virology.

[8]  H. Tachibana,et al.  E1A and ras oncogenes synergistically enhance recombinant protein production under control of the cytomegalovirus promoter in BHK-21 cells. , 1995, Bioscience, biotechnology, and biochemistry.

[9]  L. Leinwand,et al.  The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. , 1994, Gene therapy.

[10]  James M. Wilson,et al.  Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans , 1994, Nature.

[11]  C. Burant,et al.  Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. , 1994, The Journal of biological chemistry.

[12]  D. Pfaff,et al.  Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Tomasec,et al.  Herpes simplex virus 1 (HSV-1) helper co-infection affects the distribution of an amplicon encoded protein in glia. , 1994, Neuroreport.

[14]  Ru Liu,et al.  The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells , 1994, Nucleic Acids Res..

[15]  J. Wilson,et al.  Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Stow,et al.  Use of recombinant vectors derived from herpes simplex virus 1 mutant tsK for short-term expression of transgenes encoding cytoplasmic and membrane anchored proteins in postmitotic polarized cortical neurons and glial cells in vitro , 1994, Neuroscience.

[17]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Changeux,et al.  In vivo and in vitro analysis of electrical activity-dependent expression of muscle acetylcholine receptor genes using adenovirus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Sanford H. Feldman,et al.  Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors , 1993, Nature Genetics.

[20]  Blake J. Roessler,et al.  A model system for in vivo gene transfer into the central nervous system using an adenoviral vector , 1993, Nature Genetics.

[21]  M. Perricaudet,et al.  An adenovirus vector for gene transfer into neurons and glia in the brain , 1993, Science.

[22]  M. Perricaudet,et al.  Transfer of a foreign gene into the brain using adenovirus vectors , 1993, Nature Genetics.

[23]  M. Stinski,et al.  Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements , 1992, Journal of virology.

[24]  G. Wilkinson,et al.  Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. , 1992, Nucleic acids research.

[25]  J Baillie,et al.  Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. , 1992, The Journal of general virology.

[26]  K. Roemer,et al.  Activity of the simian virus 40 early promoter-enhancer in herpes simplex virus type 1 vectors is dependent on its position, the infected cell type, and the presence of Vmw175 , 1991, Journal of virology.

[27]  S. Chen‐Kiang,et al.  Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J Baillie,et al.  The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. , 1991, Nucleic acids research.

[29]  M. Cockett,et al.  The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines. , 1991, Nucleic acids research.

[30]  R. Everett,et al.  A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. , 1990, The Journal of general virology.

[31]  B. Fleckenstein,et al.  Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. , 1990, The Journal of general virology.

[32]  G. Wilkinson,et al.  NF‐kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. , 1989, The EMBO journal.

[33]  C. Gorman,et al.  The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins. , 1989, Virology.

[34]  P Ghazal,et al.  Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene , 1989, Molecular and cellular biology.

[35]  N. Stow,et al.  Complementation of a herpes simplex virus type 1 Vmw110 deletion mutant by human cytomegalovirus. , 1989, The Journal of general virology.

[36]  S. Bacchetti,et al.  Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. , 1989, Virology.

[37]  F. Graham,et al.  A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. , 1988, Virology.

[38]  M. Frame,et al.  A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence , 1988, Cell.

[39]  K. Jeang,et al.  Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus , 1987, Journal of virology.

[40]  J. Darnell,et al.  Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and beta-globin promoters , 1986, Molecular and cellular biology.

[41]  N. DeLuca,et al.  Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4 , 1985, Journal of virology.

[42]  M. Stinski,et al.  Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components , 1985, Journal of virology.

[43]  Michael Boshart,et al.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus , 1985, Cell.

[44]  G. Wilkinson,et al.  The structure of the major immediate early gene of human cytomegalovirus strain AD169. , 1985, Virus research.

[45]  J. Nevins,et al.  Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity , 1984, Molecular and cellular biology.

[46]  D. R. Thomsen,et al.  Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[47]  W. Russell,et al.  Monoclonal antibodies against adenovirus type 5: preparation and preliminary characterization. , 1981, The Journal of general virology.